期刊文献+

用药护理在替吉奥胶囊治疗老年晚期胃癌患者中的应用 被引量:1

Application of medication nursing in treatment of elderly patients with advanced gastric cancer
下载PDF
导出
摘要 目的:分析用药护理在替吉奥胶囊治疗老年晚期胃癌患者中的应用效果。方法:选取120例老年晚期胃癌患者为研究对象,按照随机数字表法将其分成对照组与研究组各60例;患者均接受替吉奥胶囊治疗,对照组给予常规护理,研究组在对照组基础上给予用药护理。结果:研究组的治疗依从率为83.3%,明显高于对照组的46.7%,差异有统计学意义(P<0.05);研究组的各项药物不良反应发生率均低于对照组,差异有统计学意义(P<0.05);研究组的护理总满意度为96.7%,高于对照组的78.3%,差异有统计学意义(P<0.05)。结论:用药护理应用于替吉奥胶囊治疗老年晚期胃癌患者中,可有效减轻药物不良反应,提高患者依从性和护理满意度,其效果优于单纯常规护理。 Objective:To analyze application effects of medication nursing in treatment of elderly patients with advanced gastric cancer.Methods:120 elderly patients with advanced gastric cancer were selected as the study subjects.They were divided into control group(n=60)and study group(n=60)according to the random number table method.All patients were treated with Tegafur Gimeracil Oteracil potassium capsule.Besides,the control group received routine nursing,while the study group was given the medication nursing based on that of the control group.Results:The treatment compliance rate of the study group was 83.3%,which was significantly higher than that of the control group(46.7%),and the difference was statistically significant(χ^2=27.854,P=0.001).The incidence of adverse drug reactions in the study group was lower than that of the control group,and the differences were statistically significant(P<0.05).The total nursing satisfaction of the study group was 96.7%,which was higher than that of the control group(78.3%),and the difference was statistically significant(P<0.05).Conclusions:The medication nursing in the treatment of the elderly patients with advanced gastric cancer can effectively alleviate the adverse drug reactions,and improve the patient compliance and nursing satisfaction.Moreover,its effects are better than the simple routine nursing.
作者 崔方方 郑彦娜 刘晓 CUI Fangfang;ZHENG Yanna;LIU Xiao(Zhengzhou Second Hospital,Zhengzhou 450006 Henan,China)
出处 《中国民康医学》 2019年第13期142-143,156,共3页 Medical Journal of Chinese People’s Health
关键词 用药护理 替吉奥胶囊 晚期胃癌 Medication nursing Tegafur Gimeracil Oteracil potassium capsule Advanced gastric cancer
  • 相关文献

参考文献5

二级参考文献48

  • 1Lei Chen,Ming-Quan Song,Hui-Zhong Lin,Lin-Hua Hao,Xiang-Jun Jiang,Zi-Yu Li,Yu-Xin Chen.Chemotherapy and resection for gastric cancer with synchronous liver metastases[J].World Journal of Gastroenterology,2013,19(13):2097-2103. 被引量:19
  • 2秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 3白坂哲彦 佃守犬山 夫他新规.经口抗癌剂TS-1(S-1).癌症化学疗法,2001,:855-864.
  • 4周际昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2005.386-388.
  • 5Miller A B, Hoogstraten B, Staquet M, et al. Reporting re- suits of cancer treatment [J]. Cancer, 1981,47 ( 1 ) : 207.
  • 6Wesolowski R, Lee C, Kim R. Is there a role for second-line chemotherapy in adavanced gastric cancer? [ J ]. Lancet Oncol, 2009,10 (9) : 903.
  • 7M Malet-Martino, R Martino. Clinical studies of three oral prodrugs of 5-Fluorouracil( Capecitabine, UFT, S-1 ) : a re- view [J]. The oncologist, 2002,7 ( 4 ) : 288.
  • 8Koizumi W. S-1 plus cisplatin vel - us S-1 alone for first line treatment of advanced gastric cancer. ( SPIRITS tri- al) :a phasem trial[J]. Lancet Oncol,2008,9(3) :215.
  • 9Koizumi W, Kurihara M, Nakano S, et al. Phase 11 study of S-I ,a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Stud- y Group[ J]. Oncology,2000,58 (3) : 191.
  • 10Ajani JA, Rodriquez W, Bodoky G, et al. Muhlcenter phase llI comparison of cisplatin/S-1 with cisplatin/infu-sional fluoronracil in advanced gastric or gastroesophageal adeno- carcinoma study : the FLAGS trial [ J ]. J Clin Oncol, 2010, 28(9) :1547.

共引文献94

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部